Nizar Tannir
MD, FACP
Professor, Department of Genitourinary Medical Oncology
👥Biography 个人简介
Nizar Tannir has led pivotal trials of belzutifan (HIF-2alpha inhibitor) in VHL disease-associated RCC and in the broader clear cell RCC population after progression on IO and VEGF-TKI. His work has helped establish belzutifan as a novel mechanistically distinct treatment for RCC. He has also contributed research on rare RCC subtypes including translocation-associated RCC and fumarate hydratase-deficient RCC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Nizar Tannir 的研究动态
Follow Nizar Tannir's research updates
留下邮箱，当我们发布与 Nizar Tannir（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment